chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Firs and Second dose done in left arm 2 days after second vaccine I had a fever and the top left of my mouth and teeth have been numb and I can?t feel anything. It?s the top 3 to 3 teeth and my gums that feel as if I was getting numbed at the dentist. It still hasn?t gone away I can?t feel my lip and my teeth hurt to chew anything and are sensitive to cold and hot and throbbing. I went to the dentist and they said it was fine. So I?m here reporting it and now I will be going to my PCP. Thank you
Chills, fever, headache, bodyaches , racing heart,  Heart racing lasted 12hrs Chills, body aches, headache and fever lasted 36hrs Took Tylenol and ibuprofen to help symptoms
soreness, redness, blotching to lt deltoid treated w/APAP or advil;
Hypertensive Crisis that required two visits to the emergency room, the immediate days after the fourth dose of Moderna's Vaccine. Hypertensive Crisis finally required hospitalization for one week and subsequent treatment to control pressure. Getting the pressure to be completely stabilized took more than a month.
Information was received from a consumer for VIOXX (1307USA004920). The consumer reported that she know people (NOS) who received ZOSTAVAX and it was "real painful and red" (onset date and outcome of the event not provided. This is one of several reports from the same source. Additional information has been requested.
Facial swelling, redness, minimal trouble breathing. In ER, given steroids, PEPCID and inhaler.
Upper arm, between elbow and shoulder, hurts 24 hrs. a day. Pain level at 6-7 with scale to 10. Sometimes feeling cold inside the effected area.
This spontaneous report was received from a health professional refers to a patient of unknown age and gender. The patient's medical history and concomitant medications were not reported. On 26-OCT-2016, the patient was vaccinated with VAQTA (lot # L015460, expiry date: 20-JUL-2017) for prophylaxis (dose and route was not reported), which was stored improperly(reported as vaccine temperature excursion) (Product storage error).
Information has been received from a health professional concerning an 86 year old female with diabetes mellitus, hypertension and hyperlipidemia who on 19-OCT-2006 at "12 noon" was vaccinated with a dose of Pneumovax 23 (lot # 651357/0391F also reported as 651400/0618F), intramuscularly in the right deltoid.  Concomitant therapy that day at 10:35 AM included FLUZONE (lot # U2202AA), intramuscularly in the left deltoid.  On 19-OCT-2006, "during night" the patient experienced rash all over her body, arm was red and arm was itching.  The patient's daughter called in AM of 20-OCT-2006 and asked if she could give her BENADRYL because arm was red/itching.  The doctor "OK'd" BENADRYL.  The patient recovered.  There were no relevant diagnostic tests or laboratory tests.  The reporter stated physician requested a lot check for lot# 651400/0618F.  The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory.  The lot met the requirements of the agency and was released.  Additional information is not expected.
There were no known COVID exposures between the first vaccine dose on 12/30/20 and the initiation of symptoms on 3/12/21. In the description below, all pain continued during the night and day, with pain causing difficulty falling and staying asleep.  3/12/21 developed burning pain over pubic bone and lower abdomen. This spread the next 1-2 days to the lower abdomen. 3/16/21 developed left sided sciatica burning pain and numbness in addition to continued pubic pain. 3/18/21 developed bilateral sciatic pain with strong burning from SI joints to below the lateral calf on each side. Burning pain and numbness started on bilateral quadriceps in individual muscle groups such that you could draw a line around the individual muscle bundles. Pain and numbness started on the left lateral upper arm and forearm. 3/23/21 searing/burning pain on bilateral inner thighs. 3/24/21 worsening of the left quad pain and bilateral right inner thigh numbness and pain  3/25/21 woke up with left forearm numbness and pain, left quad pain, left and right inner thigh numbness and pain 3/26/21 woke up with pain and burning of bilateral inner thighs, left face, left arm and forearm. Palpitations began in the evening 3/27/21 sleep was better with only mild inner thigh pain briefly in the morning and left sided sciatica, in early evening the palpitations returned as well as the inner thigh burning 3/28/21 experienced palpitations throughout the day, had mild inner thigh burning pain in the morning and then later after mild activity 3/29/21 saw healthcare provider.  Around 4/2/21 symptoms mostly resolved but since then intermittent pain in the above same areas.
diagnosed with bacterial infection at site of injection; spreading rash; rash area felt hot; raised red blob; itchy; very fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEELING HOT (rash area felt hot), RASH PAPULAR (raised red blob), PRURITUS (itchy), INJECTION SITE INFECTION (diagnosed with bacterial infection at site of injection) and RASH (spreading rash) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced FATIGUE (very fatigue). On 15-Feb-2021, the patient experienced FEELING HOT (rash area felt hot), RASH PAPULAR (raised red blob), PRURITUS (itchy) and RASH (spreading rash). On an unknown date, the patient experienced INJECTION SITE INFECTION (diagnosed with bacterial infection at site of injection). The patient was treated with CEFALEXIN (KEFLEX [CEFALEXIN]) at an unspecified dose and frequency. At the time of the report, FEELING HOT (rash area felt hot), RASH PAPULAR (raised red blob), PRURITUS (itchy), RASH (spreading rash) and FATIGUE (very fatigue) had not resolved and INJECTION SITE INFECTION (diagnosed with bacterial infection at site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Bilateral rash on face started day 3 and is worsening still on day 7.
third dose of shingrix was given to patient; This case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a 52-year-old female patient who received Herpes zoster (Shingrix) (batch number 3XR3X, expiry date 12th September 2022) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date) and Shingrix (received 2nd dose on an unknown date).   On an unknown date, the patient received the 3rd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.  Additional details were reported as follows: The age at vaccination was not reported. The pharmacist reported that a 3rd dose of Shingrix was given to the patient which led to extra dose administered. The pharmacist asked how to proceed and what to expect side effects wise. The reporter did not consent to follow up.
Sudden high fever, leading to a febrile seizure/convulsions, vomiting, trip to the ER by 3:00 AM 12/4/2011, at the ER, high doses of Tylenol and Motrin were given to resolve the fever.
patient had a red arm that was warm to the touch, swollen, and tender within 24 hours of vaccination. patient went to an urgent care where they prescribed the patient keflex to treat
Patient developed guillian bare syndrome, with lower extremity weakness and numbness 15 days after vaccination. Improved after plasma exchange therapy and inpatient rehabilitation.
This spontaneous report as received from a physician via a company representative refers to a female patient of unknown age. No medical history provided. On an unknown date the patient was vaccinated with ZOSTAVAX ("single dose"). No concomitant medications were provided. On an unknown date the patient experienced shingles. The outcome of shingles was reported as recovering. The patient sought medical attention by visiting a doctor. Additional information has been requested.
Patient states has a rash down her left arm (24 hours after receiving vaccine). Also has headache.
Case number PHEH2014US024357, is an initial spontaneous report from a nurse received on 02 Dec 2014 and a follow up report received from the nurse on 19 Jan 2015. This report refers to a 75-year-old male patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 14511P, expiry date: Mar 2015) intramuscularly in the left deltoid at a dose of 0.5 ml on 05 Nov 2014. The nurse reported that before vaccination the prefilled syringe (PFS) of FLUVIRIN was stored at 49 degree F for 1 hour and 15 minutes. No adverse event was reported following this maladministration (incorrect storage of drug). No further information was provided. Follow up report received from the nurse on 19 Jan 2015: FLUVIRIN site of vaccination was updated.
3 deaths after the second dose of the Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of DEATH (3 deaths after the second dose of the Moderna vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. Death occurred on an unknown date The cause of death was not reported. It is unknown if an autopsy was performed.            Concomitant medications were not reported.  Treatment medications were not reported.  This case concerns a unspecified patient with no reported medical history experienced serious events of death after unspecified  days after the second dose of Spikevax. The event's causality considered possible by reporter. Patient experienced AEs after second dose and no information about the first dose is available rechallenge is not applicable . The benefit-risk relationship of Spikevax is not affected by this report.   This case was linked to MOD-2021-334634, MOD-2021-334642 (Patient Link).; Sender's Comments: This case concerns a unspecified patient with no reported medical history experienced serious events of death after unspecified  days after the second dose of Spikevax. The event's causality considered possible by reporter. Patient experienced AEs after second dose and no information about the first dose is available rechallenge is not applicable .The benefit-risk relationship of Spikevax is not affected by this report.; Reported Cause(s) of Death: unknown cause of death
The morning after the vaccine was given he had body aces, sore throat, fatigue and temperature of 99.8. That evening temperature was 101. On 6/9/21, he had temperature of 100, leg pain, headache and later in the day became stuffy, was coughing, T 101, heart rate 130 and pulse ox 96.
Hives with generalized itching. Clinioc nurse administered Solu-Medrol inj 125mg and benadryl injection 50mg. After 10 minutes Itching had stopped but hives remained. patient left facility
Patient was 5 weeks pregnant & started spotting blood. Patient experienced cramping & started spotting more heavily while at family doctor around 4:30 PM. The  doctor advised patient to go to the hospital. The physician at the hospital informed the patient that she was having a miscarriage.
Rash all over body. Was given BENADRYL. Patient was referred to Allergy specialist.
Information has been received from a registered nurse through the Merck pregnancy registry concerning a 20 year old female with an ovarian cyst of left ovary (28-NOV-2006) who on 05-JAN-2007 was vaccinated in the right upper arm with a first dose of Gardasil (lot 653736/0868F). Concomitant therapy included ethinyl estradiol/norethidrone (NECON 1/35). On the day the patient was vaccinated with Gardasil she was being seen at the clinic for follow up for a cyst of her left ovary. At that time, the patient though she was beginning her period cycle. The patient also had a prescription for birth control, but it was found out that she stopped taking them on an unspecified date. The patient called the clinic on 16-JAN-2007 stating that she performed a urine home pregnancy test which was positive. On 17-JAN-2006, she was seen at the clinic. An ultrasound was performed and results revealed patient was 6 weeks, 1 day intrauterine pregnancy. The patient told the resident physician that this was an unplanned and undesired pregnancy, and she would be terminating the pregnancy. On 12-FEB-2007, at 8 weeks gestation, the patient terminated the pregnancy. The patient continued with the Gardasil series having received 3 doses. Upon internal review, the patient's induced abortion was considered an other important medical event. No additional information is expected.
Vaccine 5/18. On 5/22 4 days after vaccine, she developed right arm swelling and skin discoloration.  On 5/23 she went to the ED.  Ultrasound revealed acute, occlusive thrombosis of right subclavian vein. She was admitted to the hospital, started on enoxaparin, achieved therapeutic levels. On 5/25 she underwent thrombolysis and venogram and was confirmed to have findings consistent with Paget-Schroetter syndrome. She was discharged home on 5/25 in good condition. Note: she also has known prothrombin gene mutation G20210A that confers an increased risk of thrombosis. She does have repetitive use of the right arm (lacrosse player).
Initial report received on 03 December 2009 form a health care professional, who is also the patient's parent. A female adolescent patient (age not reported) had received a first dose of MENACTRA "about one month ago" (lot number, route, site and date of administration no reported) and approximately one to two weeks later, she experienced two to four days of nausea and began to experience hypersomnolence which continued at the time of the report (outcome also reported as unknown). According to the reporter, the patient was sleeping about 20 hours a day. The patient had no known allergies, no concurrent illness, and she had not received any other vaccines within four weeks prior to MENACTRA vaccination. No additional information was provided at the time of the report. Documents held by sender: None
Telephone call stating pt had severe allergic reaction to Typhoid oral vaccine, went to Emergency Rm. Pt states taking first dose at 11:15 am on an empty stomach with 2 glasses of water. Drove down to city and noticed feeling "jittery" about 30 minutes later, possible lip swelling, dry throat, then lightheaded, and then became very anxious. ED medication administration 9/2/17 1238 NaCl 0.9% IV soln 1000ml, stopped at 1353 (bolus only), 1346 Diphenhydramine 50mg/ml, 25 mg IV, 1346 Famotidine 40mg oral, 1500 NaCl 0.9% IV soln 1000ml, stopped at 1515 (bolus only). In Emergency room, improvement and with monitoring over several hours and agreed to go home and continue using BENADRYL every 6 hours.
Peripheral nerve and muscle involvement.   Continual ?bubbling? in lower legs and feet. Muscle  cramping on tops of feet, behind knees. Muscle spasms in legs.  Severe over 3-4 months.   Spasms and cramping has subsided some currently. ?Bubbling? continues.
This spontaneous report as received from a nurse practitioner refers to a 11 year old female patient. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 24-JUN-2015, the patient was vaccinated with a first dose of GARDASIL lot # K007264, expiry date March 2017 (strength, route and site of administration were not reported). On 13-AUG-2015, also reported as seven weeks later, the patient was vaccinated with a second dose of GARDASIL lot # K010574, expiry date April 2017 (strength, route and site of administration were not reported). On 14-JAN-2016, the patient was vaccinated with GARDASIL 9 lot # L020015, expiry date August 2017 (strength, route and site of administration were not reported), third dose in her HPV vaccination series. The patient did not report any adverse experience. Additional information has been requested.
pt was administered 0.5 ml of moderna booster injection. No adverse reaction or s/s of side effects during observation or upon pt leaving clinic.
Patient is 11 years and 10 months old.  I gave the Pfizer age 12 and over to the patient
Pt noted to have a fever up to 102 on 6/10/01. Pt was given oral antipyretic and while on mother's lap went limp and unresponsive for less than 5 minutes. Pt transported to local ER for evaluation and was noted to be fit for discharge.
Excessive sleepiness. Fever over 100 for over 24 hours even with Tylenol. Extreme difficulty breathing/could see nostrils flaring in & out with each breathe. Red Splotchy areas on face like a sunburn. Decrease in urination/bowel movements.
This case was reported by a consumer via call center representative and described the occurrence of feeling unwell in a 64-year-old male patient who received BOOSTRIX. Concurrent medical condition included blood pressure high, cholesterol (over 200) and polycythemia vera. Concomitant products included COREG, hydroxyurea; LIPITOR and ramipril. On 5th January 2015 12:00, the patient received BOOSTRIX (injection) .5 ml. On 7th January 2015, 2 days after receiving BOOSTRIX, the patient experienced feeling unwell, general body pain, dry cough, influenza-like symptoms, fever and fatigue. On an unknown date, the outcome of the feeling unwell, general body pain, dry cough, influenza-like symptoms, fever and fatigue were recovering/resolving. The reporter considered the feeling unwell, general body pain, dry cough, influenza-like symptoms, fever and fatigue to be almost certainly related to BOOSTRIX. This was 1 of the 2 cases received from the same reporter and same family. Additional details provided: The patient reported that he started to experience adverse events on Tuesday. He reported that he felt fairly sick and like he has a low grade fever.
My son began running fever hours the same evening after he received the 2nd covid vaccine, he also threw up several times. The fever ran between 101 and 104 until Friday evening. Tylenol helped keep fever down. On Saturday he was free of temperature, but by Saturday midday all of a sudden he was displaying tics. He was cranking/turning his neck and grimacing  a little seemingly unknown to him. Also some shoulder raising.  Saturday night there were a lot of these movements. Sunday morning he seemed a bit better, I saw some tics but more sporadic.  By 4pm-ish (when tired) he started to do them a little more, but not at the same peak frequency as the night before. By Monday morning (today) I didn't see very many tics before school this morning, so I sent him to school. I noticed yesterday that it seemed to start in the afternoon after he was seemingly getting fatigued.
reported Blood Pressure jumping/blood pressure shot up; nausea; headache; icky feeling; patient experienced light headedness, dizzy and icky feeling; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 80-years-old female patient received second dose of bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot Number: EN6204, Expiry date: Unknown) via an unspecified route of administration in left arm on 10Mar2021 13:30 as single dose for covid-19 immunisation. Medical history included hypertension, caller says she has had hypertension prior to getting vaccine. The patient previously took first dose of bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot Number: EN6201, Expiry date: Unknown) via an unspecified route of administration in right arm on 17Feb2021 as single dose for covid-19 immunisation. There was no family history relevant to adverse events. There were no concomitant medications. Additional Vaccines Administered on Same Date of the Pfizer Suspect. The patient had not received any other vaccine within 4 weeks prior to the vaccine. On 13Mar2021, patient experienced light headedness, dizzy and icky feeling, on 15Mar2021, experienced blood pressure jumping/blood pressure shot up and on an unspecified date patient experienced nausea and headache. Caller says she has had hypertension prior to getting vaccine.  Caller got her 2nd dose, "last Wednesday on 10Mar2021". Caller says she had no issues until Saturday/Sunday. Caller experienced: nausea, light headedness, icky feeling, headache. Caller says she has never had a "continuous headache before". Caller had a pre-existing appointment with doctor that Monday after. During appointment, caller had systolic blood pressure reading of 205.  Caller says the doctor "gave me a little orangeish coloured pill, she was monitored after that in office."  Caller says she was told to go to emergency room from doctor office. Caller had EKG and blood work done at emergency room and sent home to continue to monitor blood pressure and follow up with her doctor. Caller is asking, "has anyone else reported Blood Pressure jumping".  Caller also says, "I know people have headache and nausea, how long does that usual last"  Caller asking how long her headache might last. Dizzy/Lightheaded/Icky feeling: She said that she still has a kind of a funny headache. She said that she is never really sick and can't even remember having a cold. Caller said that her blood pressure is currently in the 140's and 150's systolic. She said that it has been high for a number of years, but it has never been as high as 205 that she can recall. Caller said that her blood pressure dropped while she was at the hospital and she was discharged from the emergency room. The caller was not admitted to the hospital. Caller does not remember the diastolic number from her blood pressure. The patient underwent lab tests and procedures on 13Mar2021, which included blood pressure measurement: systolic was 205. The outcome of the events light headedness, dizzy, icky feeling and blood pressure jumping/blood pressure shot up were recovering and nausea, headache were unknown.
A non-serious, spontaneous report of fever of 104, aches and pain was received from a physician, concerning a five-year-old female subsequent to FLUMIST. The patient was not receiving any concomitant medications and there is no relavent medical history. The patient received FLUMIST, intranasal for flu vaccination on 30-Oct-2008. On 01-Nov-2008 the child experienced fever of 104 F, aches and pain. As of 03-Nov-2008 the events resolved.
This spontaneous report as received from healthcare worker regarding male patient of an unknown age. The patient's concurrent conditions, medical history and concomitant medications were not reported. The patient received three doses of PNEUMOVAX 23 on an unspecified dates in 2003, 2009 and 2013 respectively. On an unknown date in 2008 the patient experienced pneumonia. The outcome of pneumonia was unknown. The reporter did not provide the relatedness of PNEUMOVAX 23. This is one of several reports received from the same reporter. Additional information has been requested.